Insider Transactions in Q3 2025 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2025
|
Andrew Fisher General Counsel |
SELL
Open market or private sale
|
Direct |
9,584
-2.24%
|
$124,592
$13.14 P/Share
|
|
Aug 01
2025
|
Andrew Fisher General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,888
+4.66%
|
-
|
|
Aug 01
2025
|
Lisa Deschamps Director |
SELL
Open market or private sale
|
Direct |
9,464
-10.03%
|
$123,032
$13.14 P/Share
|
|
Aug 01
2025
|
Lisa Deschamps Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+20.28%
|
-
|
|
Aug 01
2025
|
Kenneth Cunningham Director |
SELL
Open market or private sale
|
Direct |
10,808
-11.93%
|
$140,504
$13.14 P/Share
|
|
Aug 01
2025
|
Kenneth Cunningham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+20.95%
|
-
|
|
Aug 01
2025
|
Michael Austwick Director |
SELL
Open market or private sale
|
Direct |
11,288
-47.03%
|
$146,744
$13.14 P/Share
|
|
Aug 01
2025
|
Michael Austwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+50.0%
|
-
|
|
Aug 01
2025
|
Christina Ackermann Director |
SELL
Open market or private sale
|
Direct |
1,808
-2.74%
|
$23,504
$13.14 P/Share
|
|
Aug 01
2025
|
Christina Ackermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+26.7%
|
-
|
|
Aug 01
2025
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
58,336
-2.19%
|
$758,368
$13.14 P/Share
|
|
Aug 01
2025
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,888
+2.59%
|
-
|
|
Aug 01
2025
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
208,912
-1.65%
|
$2,715,856
$13.14 P/Share
|
|
Aug 01
2025
|
Mark W Hahn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
255,696
+1.98%
|
-
|
|
Aug 01
2025
|
Martin Edwards Director |
SELL
Open market or private sale
|
Direct |
10,808
-6.4%
|
$140,504
$13.14 P/Share
|
|
Aug 01
2025
|
Martin Edwards Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+12.45%
|
-
|
|
Aug 01
2025
|
David R Ebsworth Director |
SELL
Open market or private sale
|
Direct |
1,904
-0.22%
|
$24,752
$13.14 P/Share
|
|
Aug 01
2025
|
David R Ebsworth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+2.65%
|
-
|
|
Aug 01
2025
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
208,912
-1.54%
|
$2,715,856
$13.14 P/Share
|
|
Aug 01
2025
|
David Zaccardelli President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
255,696
+1.85%
|
-
|
|
Aug 01
2025
|
James Aloysius Brady Director |
SELL
Open market or private sale
|
Direct |
824
-3.43%
|
$10,712
$13.14 P/Share
|
|
Aug 01
2025
|
James Aloysius Brady Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+50.0%
|
-
|
|
Aug 01
2025
|
Anders Ullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+6.27%
|
-
|
|
Aug 01
2025
|
Vikas Sinha Director |
SELL
Open market or private sale
|
Direct |
4,328
-4.4%
|
$56,264
$13.14 P/Share
|
|
Aug 01
2025
|
Vikas Sinha Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+19.6%
|
-
|
|
Aug 01
2025
|
Mahendra Shah Director |
SELL
Open market or private sale
|
Direct |
3,608
-3.72%
|
$46,904
$13.14 P/Share
|
|
Aug 01
2025
|
Mahendra Shah Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+19.82%
|
-
|
|
Jul 08
2025
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,320
-0.72%
|
$993,520
$11.44 P/Share
|
|
Jul 08
2025
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
90,320
-0.67%
|
$993,520
$11.44 P/Share
|
|
Jul 08
2025
|
Andrew Fisher General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
39,464
-8.85%
|
$434,104
$11.44 P/Share
|
|
Jul 08
2025
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,616
-1.43%
|
$413,776
$11.44 P/Share
|
|
Jul 07
2025
|
Mark W Hahn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
229,512
+1.8%
|
-
|
|
Jul 07
2025
|
David Zaccardelli President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
229,512
+1.68%
|
-
|
|
Jul 07
2025
|
Andrew Fisher General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
86,064
+16.17%
|
-
|
|
Jul 07
2025
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
86,064
+3.17%
|
-
|